Eurofins Biomnis code

INFAC

Synonyms

• anti-Infliximab antibodies
• Anti-Remicade® antibodies
• Inflectra
• Infliximab
• Remsima

Specialty

Immunology

Clinical significance

Infliximab (Remicade(R)) is a part human part murine chimeric antibody for antigen fixation. Its target is TNF alpha. It is used in the treatment of Chrons Disease and Rheumatoid poly arthritis and can induce the patient to synthesise neutralising antibodies. For patients not responding to Remicade it is then useful to test for anti Remicade antibodies.

Preanalytics

• 1 mL :
• Serum
•   Refrigerated

• A tube specifically for this analysis : No

Further information

Avoid lipid sera and samples that have been frozen/defrosted more than once.
Always draw blood at the same time before another administration
Please attach the specific clinical information sheet (R46 : Anti-TNF)

Documents to download

• Specific clinical information form (R46-INTGB)

Methodology

Enzyme-immunoassay

Turnaround time

15 days